Early skin cancer detection is evolving fast. While biopsies remain the gold standard, new technology is helping dermatologists identify suspicious lesions earlier, more accurately, and with fewer unnecessary procedures.
From the AOCD Meeting in Orlando, we sat down with Laura Ferris to discuss how dermoscopy, mole mapping, total body photography, and emerging AI-driven tools are reshaping the future of skin cancer detection. We also dive into FDA-cleared technologies like Nevisense and Dermasensor, plus the ongoing challenge of improving dermatology access in rural communities.
As innovation continues to grow, the future of dermatology is becoming smarter, more preventative, and more patient-focused.
We talk about the real impact these delays have on patients living with eczema, psoriasis, and other inflammatory skin diseases, along with what patients can actually do to advocate for themselves. If you’ve ever been told your medication “isn’t covered,” this episode breaks down why and what happens next.
